S30 Nuclear Receptor Transrepression, Crosstalk, and Novel Signaling

Program: Symposia
Basic Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 104 (BCEC)
Hannelore Heemers, PhD, Cleveland Clinic, Cleveland, OH

Nothing to Disclose: HH
8:15 AM
Susan Katherine Logan, PhD, Urology and Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY
Nothing to Disclose: SKL
8:35 AM
Simon Chu, PhD, Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research and Monash University, Melbourne Vic, Australia
Nothing to Disclose: SC
8:55 AM
Zeynep Madak Erdogan, PhD, Food Sciences and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL
ZM: Investigator, Pfizer, Inc..
9:15 AM
Ellis R Levin, MD, Medicine, University of California-Irvine and the Long Beach VAMC, Long Beach, CA
Nothing to Disclose: ERL
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire